Lorraine A. Chantrill

University of Southern California — United States

Medicine · Health Sciences

29h-index12.4kcitations119works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(59), Cancer Genomics and Diagnostics(34), Colorectal Cancer Treatments and Studies(24), Neuroendocrine Tumor Research Advances(17), Gastric Cancer Management and Outcomes(16)

Publications118 total

Supplementary Table 3 from Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
2025Open Access
Supplementary Table 7 from Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
2025Open Access
Supplementary Table 6 from Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
2025Open Access
Table 1 from Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
2025Open Access
Supplementary Table 2 from Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
2025Open Access
Supplementary Table 4 from Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
2025Open Access
Supplementary Table 9 from Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
2025Open Access
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
Nature Medicine·2025· 8 cited
LBA9 ctDNA-guided adjuvant chemotherapy de-escalation in stage III colon cancer: Primary analysis of the ctDNA-negative cohort from the randomized AGITG DYNAMIC-III trial (Intergroup study of AGITG and CCTG)
Annals of Oncology·2025· 2 cited
Circulating tumor DNA (ctDNA) analysis guiding adjuvant therapy in patients (pts) with colorectal cancer (CRC): Impact on fear of cancer recurrence (FCR).
Journal of Clinical Oncology·2025
Neo-adjuvant chemo-immunotherapy in pancreatic cancer: Results of the Australasian Gastrointestinal Trials Group (AGITG) NEO-IMPACT pilot trial.
Journal of Clinical Oncology·2025
Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET: A randomized study of cessation of somatostatin analogues (SSA) after peptide receptor radionuclide therapy (PRRT) in mid, hind-gut, and pancreatic neuroendocrine tumours.
Journal of Clinical Oncology·2025
Treatment With a Nonaromatizable Androgen for Transgender Man With a Hormone-sensitive Ovarian Cancer
JCEM Case Reports·2025· 1 citedOpen Access
Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis
Science Advances·2025· 5 citedOpen Access
AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG)
Clinical Colorectal Cancer·2024
Chemotherapy and radiotherapy for advanced pancreatic cancer
Cochrane Database of Systematic Reviews·2024· 18 citedOpen Access
DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol
BMC Cancer·2024· 3 citedOpen Access
Expert consensus on the optimal management of <i>BRAF<sup>V600E</sup></i>‐mutant metastatic colorectal cancer in the Asia‐Pacific region
Asia-Pacific Journal of Clinical Oncology·2024· 2 citedOpen Access
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
Exploration of Targeted Anti-tumor Therapy·2024· 1 citedOpen Access
1513P Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)
Annals of Oncology·2024Open Access
page 1 of 6Next →

Frequent Co-authors

Jaswinder S. Samra(23), Anthony J. Gill(23), David K. Chang(22), Marina Pajic(22), Andrew V. Biankin(21), Amber L. Johns(20), Adnan Nagrial(20), Venessa Chin(18), Angela Chou(17), Mark Pinese(15), Jeremy L. Humphris(15), James G. Kench(15), Neil D. Merrett(13), Nigel B. Jamieson(13), Elizabeth A. Musgrove(13), Nicola Waddell(13), Mark J. Cowley(12), Ilse Rooman(12), Sean M. Grimmond(12), Nick Pavlakis(12)